In their novel approach to Drug Discovery, Maxwell and Eckhardt explore their thesis that the discovery of new drugs - especially of innovative therapeutic agents - is an independent dynamic process that demands the full attention of researchers, rather than a spontaneous consequence of investigative research. Faced with a dearth of quantitative information on how and where innovative drugs were discovered, the authors have developed considerable quantitative data about this process in order to provide a deeper understanding of its true nature. Drug Discovery: A Casebook and Analysis offers a unique quantitative survey of research since World War II that led to the development of 32 innovative therapeutic agents. Factual and concise, each chapter presents a review of the original scientific contributions associated with the discovery of a specific drug. These chapters are followed by a computer analysis of important variables and finally by an interpretation. Drug categories discussed include: cardiovascular and renal (including renal transplantation) psychiatric neurological rheumatological anesthesiological pulmonary gastrointestinal.Everyone interested in the basic or clinical research leading to important drugs - and the institutional interplay inherent in the process - will find Drug Discovery: A Casebook and Analysis a comprehensive, invaluable reference compendium!
Cardiovascular and Renal Group (Including Renal Transplantation).- Propranolol.- Captopril.- Calcium Antagonists: Verapamil, Nifedipine, Diltiazem.- Chlorothiazide.- Furosemide.- Azathioprine.- Cyclosporine.- Psychiatry Group.- Chlorpromazine.- Haloperidol.- Imipramine.- Iproniazid.- Lithium.- Chlordiazepoxide and Diazepam.- Neurology Group.- L-Dopa.- Carbamazepine.- Rheumatology Group.- Indomethacin.- D-Penicillamine.- Hydroxychloroquine.- Methotrexate.- Cyclophosphamide.- Anesthesiology Group Succinylcholine.- Halothane.- Fentanyl.- Naloxone.- Pulmonary Group.- Albuterol.- Beclomethasone Dipropionate.- Gastrointestinal Group.- Cimetidine.- Chenodeoxycholic Acid and Ursodeoxycholic Acid.- Analysis and Interpretation.- Summaries of the Analyses of Table 1.- Interpretation.- Appendix: Analyses of Tables.- I. Analysis of 30 Lines of Research.- II. Analysis of 32 Inovative Drugs.- III. Analysis of the Inovative Drugs Taken as a Groups.